Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma
about
Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and preventionDiagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysisMicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusionIdentification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot studyMicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targetsmiR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaCirculating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant MesotheliomaPlasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism.Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease.MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial functionEarly detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool.Polymorphisms in the gene regions of the adaptor complex LAMTOR2/LAMTOR3 and their association with breast cancer riskCombination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis.MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma.Chemokine (C-C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient-based study.The Impact of Hemolysis on Cell-Free microRNA Biomarkers.Malignant pleural mesothelioma: current and future perspectivesPotential role of microRNA-126 in the diagnosis of cancers: A systematic review and meta-analysisSecreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.Blockage of epithelial to mesenchymal transition and upregulation of let 7b are critically involved in ursolic acid induced apoptosis in malignant mesothelioma cell.Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.Role of microRNAs in malignant mesothelioma.Dysregulation of miRNAs and their potential as biomarkers for the diagnosis of gastric cancer.Nicotinamide N-methyltransferase in non-small cell lung cancer: promising results for targeted anti-cancer therapy.Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma.Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.Biomarkers in the prevention and follow-up of workers exposed to asbestos.Serum mesothelin and other biomarkers: what have we learned in the last decade?Targeting Nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer Cells.
P2860
Q26742027-8DEEA149-5425-48A8-A520-6277093DFEF1Q26748767-D351E2A7-CB1B-4145-B972-B246B41206C2Q28387980-3D283F31-A56A-4914-A771-8320F0D41944Q28395462-310B9159-817D-4024-8EED-D1ECD8191860Q28396395-E14E06AA-AD48-43E8-977A-ABBC1991C535Q28397829-448229F2-829B-4E8C-BB68-8D6631B2B4AEQ29248725-09F7161F-15DA-4B23-AE8A-3D4E16A6CAB4Q33637593-6EAB07F7-2392-4FBC-90F6-C20770411C7BQ33784593-55217137-FD46-4922-B8E0-B23E9718CA85Q34280453-373AF5E9-B144-43D3-AC18-89F89AFE8281Q34431793-1EE319FA-3A22-4219-B97E-F6CCA7DA012DQ34441092-FFBCFC91-A9AC-4528-BC3C-ACF4194E618CQ34558708-3CEB51D0-1F92-4507-A30F-1271C01184E4Q34627854-AB155631-26E6-4904-9D51-8A902C4CE8C5Q35511541-2572AB78-BD77-4458-8B90-DDB0F691A737Q35904195-EEA7056A-B460-4884-8EF4-493012472E94Q36872732-3413C34D-71C8-4BC9-B0E2-531E09EB831DQ37217764-206F451A-1DB2-445B-B741-5BA269B3C5B9Q37226272-264625A4-1F74-4917-9ABB-5224EDEC1808Q37240065-11CAE1BE-9AA4-40FF-B615-362582F3FC59Q37585990-64C5E9C3-E1B4-4BB6-9487-34BDF9F36393Q38119922-85B1FE9B-48D1-45E0-BC3D-745D7BB5CCE9Q38190418-56FBF6F2-36FD-493F-993C-0C30031B9BA3Q39227045-77ED4932-1B98-43C7-BB38-CF851ED57FA6Q44201011-BFC687BA-3EBC-453A-964B-D12A730D6993Q47133472-1490A8F5-FD37-4D20-9892-0E2AE59FA3F6Q49804857-07492397-AE79-4B85-B44E-DABE875A1FFBQ52672882-BAF47932-3C5E-4FAA-AEDD-F5E5259D1539Q52672883-4E5B8ACA-B0C8-44A7-9292-DCBF7088AC98Q54977358-1F169EA4-2C59-41A4-8C09-566AC1F47DE4
P2860
Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Association of MiR-126 with so ...... ker for malignant mesothelioma
@ast
Association of MiR-126 with so ...... ker for malignant mesothelioma
@en
Association of MiR-126 with so ...... ker for malignant mesothelioma
@nl
type
label
Association of MiR-126 with so ...... ker for malignant mesothelioma
@ast
Association of MiR-126 with so ...... ker for malignant mesothelioma
@en
Association of MiR-126 with so ...... ker for malignant mesothelioma
@nl
prefLabel
Association of MiR-126 with so ...... ker for malignant mesothelioma
@ast
Association of MiR-126 with so ...... ker for malignant mesothelioma
@en
Association of MiR-126 with so ...... ker for malignant mesothelioma
@nl
P2093
P2860
P50
P3181
P1433
P1476
Association of MiR-126 with so ...... ker for malignant mesothelioma
@en
P2093
Armando Sabbatini
Damiano Carbonari
Davide Sartini
Elettra Pignotti
Elisabetta Strafella
Marco Tomasetti
Monica Amati
Monica Emanuelli
Paola Mazzanti
Renzo Ranaldi
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0018232
P407
P577
2011-04-01T00:00:00Z